Crossmark

Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis

Crossref DOI link: https://doi.org/10.1007/s00210-024-03669-5

Published Online: 2024-12-19

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-Tantawy, Samar. M.

Eraky, Salma.M.

Eissa, Laila.A.
Funding

Funding for this research was provided by:

Mansoura University
License Information

Text and Data Mining valid from 2024-12-19

Version of Record valid from 2024-12-19
More Information

Article History

Received: 17 October 2024

Accepted: 22 November 2024

First Online: 19 December 2024

Declarations

:

: The study using animals strictly adhered to the ethical standards set out by the “Research Ethics Committee of the Faculty of Pharmacy at Mansoura University in Egypt” with code number: 2023—134.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below